Kopran's Q1 FY 2026-27 Quarterly Results

Result Summary

• Kopran Ltd reported a 33.3% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Jun (Q1 FY 2026-27). On a year-on-year (YoY) basis, it witnessed a growth of 13.3%.
• Its expenses for the quarter were down by 29.5% QoQ and up 15.1% YoY.
• The net profit decreased 64.5% QoQ and decreased 10.1% YoY.
• The earnings per share (EPS) of Kopran Ltd stood at 1.39 during Q1 FY 2026-27.

Financial Statments for Q1 FY 2026-27

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Kopran Ltd is a company primarily engaged in the pharmaceutical industry. It is known for manufacturing and marketing a range of pharmaceutical products, including active pharmaceutical ingredients (APIs) and formulations. The company caters to both domestic and international markets. While specific recent major developments for Kopran Ltd are not available in this dataset, it is common for companies in this sector to focus on research and development, expansion into new markets, or production capacity enhancements. Kopran Ltd's operations are likely influenced by regulatory changes, global demand for pharmaceuticals, and the competitive landscape within the pharmaceutical industry.

Revenue

In the first quarter of the financial year 2027 (Q1FY27), Kopran Ltd reported a total income of ₹156.05 crores. This marks a decrease from the previous quarter (Q4FY26), where total income stood at ₹234.11 crores, reflecting a quarter-over-quarter (QoQ) decline of 33.3%. However, compared to the same quarter in the previous year (Q1FY26), the company experienced a year-over-year (YoY) growth of 13.3%, as total income was ₹137.77 crores in Q1FY26. This data suggests fluctuations in the company's revenue streams, with significant changes both on a quarterly and annual basis.

Profitability

During Q1FY27, Kopran Ltd achieved a profit before tax (PBT) of ₹8.80 crores, a substantial decrease of 65.3% from the previous quarter's PBT of ₹25.35 crores. Compared to Q1FY26, where the PBT was ₹9.89 crores, there was a decrease of 11.0% on a YoY basis. The tax expense for Q1FY27 was ₹2.10 crores, decreasing from ₹6.48 crores in Q4FY26 and ₹2.44 crores in Q1FY26, with QoQ and YoY declines of 67.6% and 13.9%, respectively. Consequently, the profit after tax (PAT) for Q1FY27 was ₹6.70 crores, down from ₹18.87 crores in Q4FY26 and ₹7.45 crores in Q1FY26, indicating a QoQ decrease of 64.5% and a YoY decrease of 10.1%. The earnings per share (EPS) during Q1FY27 was ₹1.39, compared to ₹3.91 in Q4FY26 and ₹2.01 in Q1FY26, reflecting a QoQ decline of 64.5% and a YoY decline of 30.8%.

Operating Metrics

Kopran Ltd's total expenses in Q1FY27 were reported at ₹147.24 crores, which is a decrease from the ₹208.76 crores recorded in Q4FY26, showing a QoQ reduction of 29.5%. When compared to Q1FY26, where total expenses were ₹127.89 crores, there is a YoY increase of 15.1%. The decline in expenses on a quarterly basis may indicate cost management efforts or variability in operational activities, while the annual increase in expenses could be reflective of scaling operations or rising input costs. The financial performance metrics of Kopran Ltd, including income, expenses, and profitability indicators, reveal notable shifts across different reporting periods, offering insights into the company's operational dynamics.